316 related articles for article (PubMed ID: 32848548)
1. Amyloid Beta Immunoreactivity in the Retinal Ganglion Cell Layer of the Alzheimer's Eye.
Lee S; Jiang K; McIlmoyle B; To E; Xu QA; Hirsch-Reinshagen V; Mackenzie IR; Hsiung GR; Eadie BD; Sarunic MV; Beg MF; Cui JZ; Matsubara JA
Front Neurosci; 2020; 14():758. PubMed ID: 32848548
[TBL] [Abstract][Full Text] [Related]
2. Ocular indicators of Alzheimer's: exploring disease in the retina.
Hart NJ; Koronyo Y; Black KL; Koronyo-Hamaoui M
Acta Neuropathol; 2016 Dec; 132(6):767-787. PubMed ID: 27645291
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas.
den Haan J; Morrema THJ; Verbraak FD; de Boer JF; Scheltens P; Rozemuller AJ; Bergen AAB; Bouwman FH; Hoozemans JJ
Acta Neuropathol Commun; 2018 Dec; 6(1):147. PubMed ID: 30593285
[TBL] [Abstract][Full Text] [Related]
4. Retinal Vasculopathy in Alzheimer's Disease.
Shi H; Koronyo Y; Rentsendorj A; Fuchs DT; Sheyn J; Black KL; Mirzaei N; Koronyo-Hamaoui M
Front Neurosci; 2021; 15():731614. PubMed ID: 34630020
[TBL] [Abstract][Full Text] [Related]
5.
Sidiqi A; Wahl D; Lee S; Ma D; To E; Cui J; To E; Beg MF; Sarunic M; Matsubara JA
Front Neurosci; 2020; 14():713. PubMed ID: 32719582
[TBL] [Abstract][Full Text] [Related]
6. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.
Koronyo-Hamaoui M; Koronyo Y; Ljubimov AV; Miller CA; Ko MK; Black KL; Schwartz M; Farkas DL
Neuroimage; 2011 Jan; 54 Suppl 1():S204-17. PubMed ID: 20550967
[TBL] [Abstract][Full Text] [Related]
7. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.
Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN
Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's Retinopathy: Seeing Disease in the Eyes.
Mirzaei N; Shi H; Oviatt M; Doustar J; Rentsendorj A; Fuchs DT; Sheyn J; Black KL; Koronyo Y; Koronyo-Hamaoui M
Front Neurosci; 2020; 14():921. PubMed ID: 33041751
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
10. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
11. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
12. Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer's disease.
Golzan SM; Goozee K; Georgevsky D; Avolio A; Chatterjee P; Shen K; Gupta V; Chung R; Savage G; Orr CF; Martins RN; Graham SL
Alzheimers Res Ther; 2017 Mar; 9(1):13. PubMed ID: 28253913
[TBL] [Abstract][Full Text] [Related]
13. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.
Koronyo Y; Biggs D; Barron E; Boyer DS; Pearlman JA; Au WJ; Kile SJ; Blanco A; Fuchs DT; Ashfaq A; Frautschy S; Cole GM; Miller CA; Hinton DR; Verdooner SR; Black KL; Koronyo-Hamaoui M
JCI Insight; 2017 Aug; 2(16):. PubMed ID: 28814675
[TBL] [Abstract][Full Text] [Related]
14. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
Attems J; Lintner F; Jellinger KA
Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
[TBL] [Abstract][Full Text] [Related]
16. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN
Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155
[TBL] [Abstract][Full Text] [Related]
17. Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.
Doustar J; Torbati T; Black KL; Koronyo Y; Koronyo-Hamaoui M
Front Neurol; 2017; 8():701. PubMed ID: 29312125
[TBL] [Abstract][Full Text] [Related]
18. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
Thal DR; Attems J; Ewers M
J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
[TBL] [Abstract][Full Text] [Related]
19. Ocular biomarkers of Alzheimer's disease.
Heaton GR; Davis BM; Turner LA; Cordeiro MF
Cent Nerv Syst Agents Med Chem; 2015; 15(2):117-25. PubMed ID: 25788142
[TBL] [Abstract][Full Text] [Related]
20. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]